Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Epocrates Inc. Shareholders
Kirby McInerney LLP is investigating potential claims against the Board
of Directors of Epocrates Inc. (“Epocrates” or the “Company”) (EPOC)
related to the proposed acquisition of the Company by Athenahealth Inc.
(“Athenahealth”) (ATHN). Under the terms of the proposal, Athenahealth
will acquire all of the outstanding common stock of Epocrates for $11.75
per share in cash, or approximately $293 million.
The investigation concerns whether the Epocrates Board of Directors is
violating its fiduciary duties in connection with the proposal and
whether the $11.75 per share consideration adequately values Epocrates
common shares. The offer price represents a mere 22% premium to the
price of shares on January 4, 2013, the day before the transaction was
announced, and analysts have set price targets for Epocrates stock as
high as $15.00.
If you are an Epocrates shareholder and wish to obtain additional
information, please contact J. Brandon Walker, Esq. by email at bwalker@kmllp.com,
or by telephone at (212) 699-1145 or (888) 529-4787, or fill
out a contact form.
Kirby McInerney LLP is a New York-based law firm concentrating in
securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to www.kmllp.com.
